Rahway-based Merck to acquire Cidara in $9.2B dealBy jay.trebleNovember 15, 2025Listen to this article The basics: Merck to acquire Cidara for $9.2B, gaining experimental flu antiviral CD388 CD388 is a potential single-dose, universal flu prevention now…
3
4
5
